S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:IBBJ

Defiance Nasdaq Junior Biotechnology ETF Stock Forecast, Price & News

$28.88
-0.34 (-1.16 %)
(As of 10/15/2021 12:00 AM ET)
Add
Today's Range
$28.88
$29.14
50-Day Range
$27.91
$31.62
52-Week Range
$27.00
$41.45
Volume512 shs
Average Volume4,762 shs
Market Capitalization$7.22 million
P/E RatioN/A
Dividend Yield1.03%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IBBJ News and Ratings via Email

Sign-up to receive the latest news and ratings for Defiance Nasdaq Junior Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Defiance ETFs
Fund NameDefiance Nasdaq Junior Biotechnology ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:IBBJ
Inception Date8/4/2020
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Junior Biotechnology Index
CategoryHealth Care
FocusSector
Development LevelBlended Develoment
RegionGlobal

Fund Statistics

Assets Under Management$4.22 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.45%
Other Expenses0.00%
Total Expenses0.45%
Fee Waiver0.00%
Net Expenses0.45%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorDefiance ETFs, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market Maker

Geographic Exposure of IBBJ

Currency Exposure of IBBJ

Sector Exposure of IBBJ

Industry Exposure of IBBJ













Defiance Nasdaq Junior Biotechnology ETF (NASDAQ:IBBJ) Frequently Asked Questions

What stocks does MarketBeat like better than Defiance Nasdaq Junior Biotechnology ETF?

Wall Street analysts have given Defiance Nasdaq Junior Biotechnology ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Defiance Nasdaq Junior Biotechnology ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Defiance Nasdaq Junior Biotechnology ETF?

Defiance Nasdaq Junior Biotechnology ETF saw a decrease in short interest in September. As of September 30th, there was short interest totaling 4,600 shares, a decrease of 37.0% from the September 15th total of 7,300 shares. Based on an average trading volume of 2,700 shares, the short-interest ratio is presently 1.7 days.
View Defiance Nasdaq Junior Biotechnology ETF's Short Interest
.

How often does Defiance Nasdaq Junior Biotechnology ETF pay dividends? What is the dividend yield for Defiance Nasdaq Junior Biotechnology ETF?

Defiance Nasdaq Junior Biotechnology ETF announced a quarterly dividend on Monday, December 28th. Shareholders of record on Wednesday, December 30th will be paid a dividend of $0.30 per share on Thursday, December 31st. This represents a $1.20 annualized dividend and a dividend yield of 4.16%. The ex-dividend date is Tuesday, December 29th.
View Defiance Nasdaq Junior Biotechnology ETF's dividend history
.

Is Defiance Nasdaq Junior Biotechnology ETF a good dividend stock?

Defiance Nasdaq Junior Biotechnology ETF pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.03%.
View Defiance Nasdaq Junior Biotechnology ETF's dividend history.

What is Defiance Nasdaq Junior Biotechnology ETF's stock symbol?

Defiance Nasdaq Junior Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBBJ."

How do I buy shares of Defiance Nasdaq Junior Biotechnology ETF?

Shares of IBBJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Defiance Nasdaq Junior Biotechnology ETF's stock price today?

One share of IBBJ stock can currently be purchased for approximately $28.88.

How much money does Defiance Nasdaq Junior Biotechnology ETF make?

Defiance Nasdaq Junior Biotechnology ETF has a market capitalization of $7.22 million.


This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.